National Health Investors (NYSE:NHI) Announces Earnings Results, Beats Estimates By $0.31 EPS

National Health Investors (NYSE:NHI) issued its quarterly earnings results on Monday. The real estate investment trust reported $1.15 EPS for the quarter, topping the consensus estimate of $0.84 by $0.31, FiscalAI reports. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The firm had revenue of $121.32 million for the quarter, compared to analysts’ expectations of $72.12 million.

National Health Investors Trading Down 1.4%

Shares of NHI stock traded down $1.07 during trading hours on Monday, reaching $74.23. 297,801 shares of the stock traded hands, compared to its average volume of 435,157. National Health Investors has a 1-year low of $67.94 and a 1-year high of $91.38. The business has a fifty day moving average price of $75.13 and a 200 day moving average price of $79.60. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $3.60 billion, a PE ratio of 23.95, a PEG ratio of 3.38 and a beta of 0.51.

Wall Street Analyst Weigh In

NHI has been the topic of a number of research reports. Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Truist Financial reduced their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday, June 12th. Cantor Fitzgerald restated an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, National Health Investors currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

Insider Buying and Selling

In other news, CEO D. Eric Mendelsohn acquired 1,500 shares of the stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the transaction, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the business’s stock in a transaction on Monday, June 15th. The shares were purchased at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director owned 44,159 shares in the company, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

Several hedge funds have recently bought and sold shares of the business. Smartleaf Asset Management LLC grew its position in National Health Investors by 35.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,630 shares of the real estate investment trust’s stock worth $126,000 after acquiring an additional 424 shares in the last quarter. Ieq Capital LLC acquired a new stake in shares of National Health Investors in the 4th quarter valued at $240,000. Orion Porfolio Solutions LLC bought a new stake in National Health Investors in the fourth quarter worth $212,000. Cibc World Markets Corp bought a new stake in National Health Investors in the fourth quarter worth $238,000. Finally, Renaissance Group LLC increased its position in National Health Investors by 3.8% during the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after buying an additional 117 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.